Product Information
BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Advagen Pharma Ltd., priced at $0.1919 per EA under NDC 72888022101. Its NADAC has been published 29 times since Feb 4, 2026.
FDA first approved this application on May 19, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB
benazepril hydrochloride and hydrochlorothiazideStrength
20; 12.5 mg/1; mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888022101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020033FDA Approved
5/19/1992
TE Code
AB
On Market Since
12/5/2024
Pharmacological Classes
Price Statistics
The NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 29 times since Feb 4, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1919 per EA |
|---|---|
| All-time high | $0.1944 (May 13, 2026) |
| All-time low | $0.1742 (Jul 22, 2026) |
| 52-week high | $0.1944 |
| 52-week low | $0.1742 |
| Median price | $0.1863 |
| Average price | $0.1849 |
| Largest weekly change | +10.1% (Aug 19, 2026) |
| Weeks tracked | 29 |
| Tracking since | Feb 4, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Advagen Pharma Ltd., is $0.1919 per EA (NDC 72888022101), effective Aug 19, 2026.
How has the price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has held within roughly two percent of its current level. It has been tracked across 29 weekly CMS publications since Feb 4, 2026.
What are the highest and lowest recorded NADAC prices for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
Since Feb 4, 2026, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.1742 (Jul 22, 2026) to a high of $0.1944 (May 13, 2026), with a median of $0.1863 per EA.
Are there cheaper alternatives to BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 72888022101) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.